IPP Bureau

Moderna reshapes leadership and ops model as it pushes into oncology, rare disease
Moderna reshapes leadership and ops model as it pushes into oncology, rare disease

By IPP Bureau - June 18, 2026

CEO Stéphane Bancel framed the changes as essential to scaling the business

Siegfried opens major API manufacturing facility in Germany
Siegfried opens major API manufacturing facility in Germany

By IPP Bureau - June 18, 2026

The expansion adds 100 m³ of reactor capacity, significantly strengthening Siegfried’s position among the world’s leading CDMOs for small-molecule drug substances

Pharma PLI scheme attracted Rs. 42,694 crore investments, created 1.13 lakh jobs in 6 years: Govt
Pharma PLI scheme attracted Rs. 42,694 crore investments, created 1.13 lakh jobs in 6 years: Govt

By IPP Bureau - June 18, 2026

As per the Department of Pharmaceuticals, the sector has expanded its reach across the country while strengthening domestic production capabilities and innovation

Suven reports positive Phase 2b results for Ropanicant in major depressive disorder
Suven reports positive Phase 2b results for Ropanicant in major depressive disorder

By IPP Bureau - June 18, 2026

Suven has already begun planning a global Phase 3 registrational program for MDD based on the results

AbbVie's Allergan wins FDA nod for first injectable targeting neck lines
AbbVie's Allergan wins FDA nod for first injectable targeting neck lines

By IPP Bureau - June 18, 2026

The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance

Bayer seals $300 million Perfuse deal
Bayer seals $300 million Perfuse deal

By IPP Bureau - June 18, 2026

Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline

Avio Smart appoints Sandeep Pandya to lead global healthcare expansion
Avio Smart appoints Sandeep Pandya to lead global healthcare expansion

By IPP Bureau - June 18, 2026

Veteran healthcare executive to drive international growth, strategic partnerships, and global commercialization of the company's molecular diagnostics portfolio

Lupin secures 180-day exclusivity for generic Azilsartan Medoxomil tablets in U.S. market
Lupin secures 180-day exclusivity for generic Azilsartan Medoxomil tablets in U.S. market

By IPP Bureau - June 18, 2026

Company introduces bioequivalent version of Edarbi for hypertension treatment following U.S. FDA approval; product recorded annual U.S. sales of USD 53.5 million

Brinton Pharma appoints Sathya Narayanan as CEO – India and JPAC
Brinton Pharma appoints Sathya Narayanan as CEO – India and JPAC

By IPP Bureau - June 18, 2026

Industry veteran with over two decades of experience to lead expansion across India, South Asia, Southeast Asia, and other high-growth healthcare markets

IMA and Abbott declare June 21 as Vitamin D Day of India
IMA and Abbott declare June 21 as Vitamin D Day of India

By IPP Bureau - June 18, 2026

New annual observance aims to promote safe sun exposure, screening, and preventive healthcare as nearly 77% of Indians are estimated to be Vitamin D deficient

proRITHM named among top 4 AI-based healthcare technologies
proRITHM named among top 4 AI-based healthcare technologies

By IPP Bureau - June 18, 2026

AI-powered remote patient monitoring platform earns recognition at AI in Healthcare 2.0 for advancing continuous, preventive, and personalized healthcare delivery

More men under 50 seeking help for low testosterone: Apollo Spectra Hospital
More men under 50 seeking help for low testosterone: Apollo Spectra Hospital

By IPP Bureau - June 18, 2026

Hospital data reveals a sharp rise in consultations related to hormonal health, erectile dysfunction and male fertility, highlighting growing awareness among younger men.

Indian Pharmacopoeia Commission delegation attends WHO-led international meet in Brazil
Indian Pharmacopoeia Commission delegation attends WHO-led international meet in Brazil

By IPP Bureau - June 18, 2026

Highlights India’s advances in pharmacopoeial science, regulatory standards, and global harmonization efforts at the 16th International Meeting of World Pharmacopoeias

ARScience Biotherapeutics appoints Gustavo Mahler as CEO
ARScience Biotherapeutics appoints Gustavo Mahler as CEO

By IPP Bureau - June 17, 2026

Mahler brings more than 20 years of leadership experience spanning cell therapy, biopharmaceutical development, manufacturing, and global business management

Glenmark launches generic Methylene Blue Injection in US market
Glenmark launches generic Methylene Blue Injection in US market

By IPP Bureau - June 17, 2026

Generic launch targets a US$19 million market in United States, strengthening Glenmark’s institutional and injectable product portfolio in North America

Latest Stories

Interviews

Packaging